Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal

The Lancet

Volumn 377, Issue 9772, 2011, Pages 1155-1161

  Warriner, I K ^a   Wang, Duolao ^b   Huong, N T My ^a   Thapa, Kusum ^c   Tamang, Anand ^d   Shah, Iqbal ^a   Baird, David T ^e   Meirik, Olav ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Paropakar Maternity and Women's Hospital   (Nepal)

^d Centre for Research on Environment Health and Population Activities (CREHPA)   (Nepal)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABDOMINAL PAIN; ADULT; ARTICLE; CHILL; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ABORTION; MULTICENTER STUDY; NAUSEA; NEPAL; PATIENT SELECTION; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RURAL AREA; TREATMENT OUTCOME; VOMITING;

EID: 79953275741     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)62229-5     Document Type: Article

References (27)

1. S Singh, D Wulf, R Hussain, A Bankole, G Sedgh Abortion worldwide: a decade of uneven progress 2009 Guttmacher Institute New York
2. WHO Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008 6th edn. 2011 World Health Organization Geneva (in press).
3. MW Rodger, DT Baird Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary Lancet 330 1987 1415 1418 (Pubitemid 18010316)
4. J Yarnall, Y Swica, B Winikoff Non-physician clinicians can safely provide first trimester medical abortion Reprod Health Matters 17 2009 61 69
5. B McPake, K Mensah Task shifting in health care in resource-poor countries Lancet 372 2008 870 871
6. WHO Task shifting: global recommendations and guidelines 2007 World Health Organization Geneva
7. IK Warriner, O Meirik, M Hoffman Rates of complication in first-trimester manual vacuum aspiration abortion done by doctors and mid-level providers in South Africa and Vietnam: a randomised controlled equivalence trial Lancet 368 2006 1965 1972 (Pubitemid 44830074)
8. A Tamang, J Tamang Availability and acceptability of medical abortion in Nepal: health care providers' perspectives Reprod Health Matters 13 2005 110 119 (Pubitemid 41617968)
9. A Pradhan, BK Suvedi, S Barnett Nepal maternal mortality and morbidity study, 2008/2009 2010 Family Health Division, Department of Health Services, Government of Nepal Kathmandu, Nepal
10. D Moher, S Hopewell, KF Schulz for the CONSORT Group CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trial BMJ 340 2010 c869
11. KF Schulz, DG Altman, D Moher for the CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials BMJ 340 2010 c332
12. H von Hertzen, G Piaggio, NT My Huong for the WHO Research Group on Postovulatory Methods of Fertility Regulation Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial Lancet 369 2007 1938 1946 (Pubitemid 46881170)
13. BL Wiens Choosing an equivalence limit for noninferiority or equivalence studies Control Clin Trials 23 2002 2 14 (Pubitemid 34164354)
14. G Piaggio, DR Elbourne, DG Altman, SJ Pocock, SJ Evans for the CONSORT Group Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement JAMA 295 2006 1172 1174
15. SD Iyengar Introducing medical abortion within the primary health system: comparison with other health interventions and commodities Reprod Health Matters 13 2005 13 19 (Pubitemid 41617957)
16. B Ganatra, M Bygdeman, PB Thuy, NG Vinh, VM Loi From research to reality: the challenges of introducing medical abortion into service delivery in Vietnam Reprod Health Matters 12 24 suppl 2004 105 113 (Pubitemid 40712250)
17. JB Samora, N Leslie The role of advanced practice clinicians in the availability of abortion services in the United States J Obstet Gynecol Neonatal Nurs 36 2007 471 476
18. C Joffe, S Yanow Advanced practice clinicians as abortion providers: current developments in the United States Reprod Health Matters 12 24 suppl 2004 198 206 (Pubitemid 40712261)
19. M Berer Provision of abortion by mid-level providers: international policy, practice and perspectives Bull World Health Organ 87 2009 58 63
20. PW Ashok, A Templeton, PT Wagaarachchi, GM Flett Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases BJOG 109 2002 1281 1289 (Pubitemid 36164756)
21. OS Tang, CC Chan, EH Ng, SW Lee, PC Ho A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation Human Reprod 18 2003 2315 2318 (Pubitemid 37427810)
22. H von Hertzen, H Honkanen, G Piaggio WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy BJOG 110 2003 808 818 (Pubitemid 37159265)
23. C Karki, H Pokharel, A Kushwaha, D Manandhar, H Bracken, B Winikoff Acceptability and feasibility of medical abortion in Nepal Int J Gynaecol Obstet 106 2009 39 42
24. Medical Abortion Task Force Medical abortion in six pilot districts of Nepal: implementation results (January-June 2009) 2009 FHD/DoHS/Ministry of Health and Population Nepal
25. DT Baird Medical abortion in the first trimester Best Pract Res Clin Obstet Gynaecol 16 2002 221 236 (Pubitemid 41123417)
26. WHO Safe abortion: technical and policy guidance for health systems 2003 World Health Organization Geneva
27. FHD/Ipas/CREHPA Summary Report: Nepal Comprehensive Abortion Care (CAC) National Facility-based Abortion Study 2006 2006 FHD/Ipas/CREHPA Kathmandu, Nepal